⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BCDA News
BioCardia, Inc. Common Stock
Congestive Heart Failure Market to Register Immense Growth at a CAGR of 8% During the Forecast Period (2026-2036) | DelveInsight
prnewswire.com
CYTK
NVO
BCDA
AZN
BMY
LLY
MESO
ASMB
LXRX
VTRS
AMGN
IRWD
NVS
MRK
Form 8-K
sec.gov
BCDA
BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities
globenewswire.com
BCDA
Form 8-K
sec.gov
BCDA
Form 8-K
sec.gov
BCDA
BioCardia Announces $4.4 Million Financing
globenewswire.com
BCDA
Form 8-K
sec.gov
BCDA
FDA Confirms CardiAMP HF II May Support Premarket Approval of CardiAMP Cell Therapy for Ischemic HFrEF
globenewswire.com
BCDA
Form 8-K
sec.gov
BCDA
BioCardia Announces Japan PMDA Record Of Advice Supports Regulatory Submission For Approval Of CardiAMP Cell Therapy For Ischemic Heart Failure
globenewswire.com
BCDA